🇮🇱 Israel Country × Condition
parkinson disease Clinical Trials in Israel
Active clinical trials for parkinson disease with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇮🇱 Israel
Active Trials in Israel (2)
NCT04388969
Recruiting
World Data on Ambroxol for Patients With GD and GBA Related PD
Enrollment
300 pts
Country
🇮🇱 Israel
Shaare Zedek Medical Center
View Trial → NCT04706234
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Enrollment
350 pts
Country
🇮🇱 Israel
Kliniken Beelitz GmbH
View Trial → Frequently Asked Questions
How many parkinson disease clinical trials are active in Israel?
There are currently 2 active clinical trials for parkinson disease with sites in Israel, of which 2 are actively recruiting patients.
How can I join a parkinson disease clinical trial in Israel?
To join a parkinson disease clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are parkinson disease trials in Israel?
Active parkinson disease trials in Israel span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology